Skip to main content

Carisma Therapeutics Inc.

CARMDelisted Dec 15, 2025
Industry
Pharmaceutical Preparations
SEC CIK
0001485003

Carisma Therapeutics Inc. was delisted on Dec 15, 2025; its insiders filed their last Form 4 on Oct 8, 2025; 33 institutions reported holding it in 13F filings for Q3 2025, worth $842.6K in total; no superinvestor held it.

Q2 2025 vs. Q1 2025

How the institutions holding Carisma Therapeutics Inc. changed between Q1 2025 and Q2 2025.

All holders in Q2 2025All holders in Q1 2025

13F holders of CARM: Q1 2025 compared with Q2 2025
MeasureQ1 2025Q2 2025Change
Holders3736−1
Shares5.58M3.98M−1.59M (−28.6%)
Value$1.73M$1.56M−$171.5K (−9.9%)

New holders (5)

Institutions that held Carisma Therapeutics Inc. at the end of Q2 2025 but not at the end of Q1 2025.

Institutions new to CARM in Q2 2025
InstitutionSharesValue% of portfolio
Jane Street Group, LLC150,810$59.1K0.00%
GTS Securities LLC50,118$19.6K0.00%
Goldman Sachs Group Inc13,026$5.10K0.00%
Baader Bank INC18,404$4.45K0.00%
Raymond James Financial Inc75$290.00%

Sold out (6)

Institutions that held Carisma Therapeutics Inc. at the end of Q1 2025 and filed for Q2 2025 without it.

Institutions that sold out of CARM in Q2 2025
InstitutionShares, Q1 2025Value, Q1 2025
Universal- Beteiligungs- und Servicegesellschaft mbH200,000$62.0K
Stratos Wealth Partners, LTD.22,200$6.88K
LPL Financial LLC20,895$6.48K
StoneX Group Inc.10,732$3.33K
Federated Hermes, Inc.5,629$1.75K
Peoples Bank250$77